Loading Events

« All Events

  • This event has passed.

Annual Biotech in Europe Forum 2020

September 21 - September 24

Annual Biotech in Europe Forum 2020

Annual Biotech in Europe Forum – The 20th Annual Biotech in Europe Forum is recognized as the leading international stage for those interested in investing and partnering in the biotech and life science industry. This highly transactional event draws together an exciting cross-section of early-stage/pre-IPO, late-stage, and public companies with leading investors, analysts, money managers, and pharma licensing executives. Supported and designed by leading figures within Europe’s pharmaceutical and biotech industry, this event will once again be covered by our regular media partners. Digital Conference; Sept 21-24, 2020

Under current circumstances including travel restrictions, we have decided that for the first time #Sachs_BEF will be held in a digital format. This will allow us to support our community and past attendees. We will provide both the usual stimulating program and networking opportunities through the video online meeting system. We expect most of our past attendees to participate and all our sponsors Gold Sponsor: LifeSci Advisors; Silver Sponsors: BeiGene, Torreya Partners LLP; Bronze Sponsor: Euronext Paris S.A.; Contributing Sponsors: Amazon Web Services (AWS), BioMedPartners AG, Novo Holdings A/S have agreed to support the digital event. The 8th Annual HealthTech Innovation Forum is merged with the 2nd Annual HealthTech CEO Forum, scheduled for March 2nd, 2021 at Hilton Zurich.

The Digital 20th Annual BEF is going to take place on the 21st -24th of September with the main program being spread throughout 4 days and will feature more than five hours each day of high-level speeches and panel discussions. In addition, there is a global company showcase of 50+ presentations by corporates, offering innovative solutions, and looking for capital and partnerships. We estimate 700+ registered on the portal and watching part/all sessions and at least the same amount of views from videos on-demand after the event. Meetings will take place from September 21st to 25th and from September 28th to October 2nd. Moreover, the system will be open for 12 hours a day and we expect over 2000 meetings completed over 10 days.​ The digital event will consist of:

Day 1: Bio-Pharma & HealthTech: Pandemic Response Day

  • Industry Leaders Response Session
  • Vaccines Panel & Showcase
  • Therapeutic Strategies to Prevent & Treat Covid-19 Panel & Showcase
  • Point of Care Diagnostics Panel

Day 2: BioTech & HealthTech Capital Investment Day

  • Bio-Pharma in a New Era Panel
  • Accessing US Capital Markets from Europe Panel
  • IPO BootCamp
  • Revolution in Cell Based Therapies Across Therapeutics Panel & Showcase
  • VC & Private Equity: Addressing All Opportunities, Including Crossover Transactions Panel & Showcase
  • Early Stage Investment Panel

Day 3: Bio-Pharma Partnering & Therapeutics Day

  • Pharma DealMaking Panel
  • Immuno-Oncology BD&L Panel & Showcase
  • Advanced Therapies in Immuno-Oncology Panel & Showcase
  • Exciting Opportunities in Krakow, Poland – Life Science is Growing Here Workshop
  • Platform Technologies & Novel Therapeutics Panel & Showcase

Day 4: Neuroscience Investor Day

  • CNS Partnering & DealMaking Panel & Showcase
  • Progress in AD & PD Panel & Showcase
  • Advanced Therapeutics Panel & Showcase
  • Advances in NeuroTech, Software & Diagnostics Panel
  • Medical Cannabis in Europe Panel
  • Industry & Investor Roundtable
Confirmed Keynote Speakers Include:
  • Harry Tracy, President, NI Research Inc.
  • “Mobilizing a Response to COVID” by Mark Stevenson, Chief Operating Officer, Thermo Fisher Scientific
  • “Thinking a Few Steps Ahead: Developing Covid Products for Beyond the Pandemic” by Peter Kolchinsky, Managing Director, RA Capital Management, LLC
  • Jonathan Javitt, Chairman & CEO, NeuroRx, Inc.
  • More TBA…
Confirmed Speakers and Chairs:

  • Alain Vertès, Managing Director, NxR Biotechnologies GmbH
  • Alberto Santagostino, SVP, Head of Cell & Gene Technologies, Lonza AG
  • Alexander Breidenbach, Founder and Entrepreneur-in-Residence, KetteRx GmbH
  • Andrei Floroiu, President & CEO, Vaxart, Inc.
  • Andrew Allen, Co-Founder, President & CEO, Gritstone Oncology
  • Anja König, Global Head, Novartis Venture Fund
  • Anna Lisa Picciolo-Lehrke, Head Business Development Neurology, UCB Pharma
  • Anne Altmeyer, Chief Business Officer, Sigilon Therapeutics, Inc.
  • Austin Speier, Chief Strategy Officer, Click Therapeutics, Inc.
  • Beth Shafer, Head, Neuroscience and Drug Discovery Sciences Business Development, CEI, Takeda Pharmaceuticals Co., Ltd.
  • Bibhash Mukhopadhyay, Principal, New Enterprise Associates (NEA)
  • Chandra Leo, Investment Advisor, HBM Partners AG
  • Chris Maggos, Managing Director, Head of Europe, LifeSci Advisors
  • Christian Jung, Partner, Dementia Discovery Fund
  • Corinne Venot, Senior Director, Business Development, BeiGene Ltd
  • Dennis Purcell, Founder, Aisling Capital LLC
  • Eduardo Vianna, CEO, NovaGo Therapeutics AG
  • Edward Littler, COO, ReViral Ltd.
  • Edyta Jaworska, Integrated Drug Discovery Director and Management Board Member, Selvita S.A.
  • Eric de La Fortelle, Venture Partner, Seventure Partners
  • Erik Manting, CEO, DCPrime B.V.
  • Esteban Pombo-Villar, CEO, TargImmune Therapeutics AG
  • Frederic Cren, CEO, Inventiva Pharma
  • Frederic Ors, CEO, IMV Inc.
  • Gil Bar-Nahum, Managing Director, EMEA Head of Biotechnology, Jefferies International Ltd.
  • Gilead Raday, COO, RedHill Biopharma Ltd.
  • Giovanni Mariggi, Partner, Medicxi
  • Guy Spigelman, EMEA Lead, Healthcare & Life Sciences Startups, Amazon Web Services (AWS)
  • Hubert Birner, Managing Partner, TVM Life Science Management GmbH
  • Isabella Schidrich, Senior Managing Director, Nasdaq
  • Janusz Homa, CEO, ARDIGEN SA
  • Joachim Vogt, Director Search & Evaluation Western Europe, AbbVie Deutschland GmbH Co. KG
  • Joel Sandler, Principal, Cello Health BioConsulting
  • Johan Van Hoof, Global Therapeutic Area Head, IDV Vaccines, Janssen Vaccines & Prevention B.V.
  • Juergen Gamer, VP BD, Apogenix AG
  • Justyna Czyszek, Investor Services Specialist, Krakowski Park Technologiczny sp. z o.o.
  • Karen Wagner, Managing Partner, Ysios Capital
  • Katya Smirnyagina, Partner, Capricorn Partners NV
  • Kieran Rooney, VP, Strategic Alliances & Licensing, Amryt Pharma Plc
  • Leszek Skowron, Life Science Ivestment Director, INNOventure Sp. z o.o.
  • Lior Teitelbaum, CBO, FutuRx Ltd.
  • Lubor Gaal, SVP, Head of Europe, Locust Walk
  • Lynn Durham, Founder & CEO, STALICLA S.A.
  • Maciek Drozdz, Co-Founder, Antagonis Biotherapeutics GmbH, former Principal of Venture Investments, JJDC
  • Manuel López-Figueroa, Scientific Liaison, Pritzker Neuropsychiatric Disorders Research Consortium
  • Marc Lakmaaker, Founder, Clearview Capital
  • Marco Baptista, VP, Research Programs, The Michael J. Fox Foundation for Parkinson’s Research
  • Mark Altmeyer, President & CEO, Arvelle Therapeutics
  • Markus Hosang, General Partner, BioMedPartners AG
  • Martin Potgeter, Vice President, Corporate Business Development, QIAGEN GmbH
  • Matthias Müllenbeck, Executive Director & Head Global Licensing & BD Enabling Technologies, Merck KGaA
  • Max Herrman, Managing Director, Stifel Financial Corp.
  • Melissa McCracken, Principal, Nextech Invest Ltd.
  • Michael Altorfer, CEO, Swiss Biotech Association
  • Michael Rice, Principal, Head of Advanced Therapeutics, Cello Health BioConsulting
  • Miguel Forte, CEO, Bone Therapeutics SA
  • Mike Romanos, Co-Founder & CEO, Microbiotica Ltd.
  • Murali Gopalakrishnan, Sr. Director, Head of Search & Evaluation – Neuroscience, Corporate Strategy Office, AbbVie, Inc.
  • Nanna Luneborg, Venture Partner, Novo Ventures
  • Nicholas Moore, Managing Director, Healthcare Investment Banking, Stifel Financial Corp.
  • Nick Woolf, Chief Executive Officer of AusCann Group Holdings Ltd.
  • Nicolaas Faes, Analyst, Bryan, Garnier & Co
  • Niels Emmerich, VP, Global Head Search & Evaluation, AbbVie, Inc.
  • Nissim Darvish, Senior Managing Director, OrbiMed Advisors LLC
  • Patrick Benz, Sr. Director Alliance Management, The Janssen Pharmaceutical Companies of Johnson & Johnson
  • Paul Matteis, Managing Director, Co-Head of Biotech Research, Stifel Financial Corp.
  • Peter Sandor, SVP, PFL Oncology, Astellas Pharma, Inc.
  • Peter Thompson, Partner, OrbiMed Advisors LLC
  • Phil L’Huillier, Head of Business Development, Europe & Middle East, MSD
  • Philippe Lopes-Fernandes, Senior VP, Global Head of Licensing, Business Development and Alliance Management, Merck Serono
  • Rainer Metzger, Head of Integrated Clinical Services, Medicover AB
  • Rao Movva, Novartis Distinguished Scientist & Independent Pharma & Biotech Advisor, Independent
  • Reagan Jarvis, Co-Founder & CEO, Anocca AB
  • Regina Hodits, Managing Partner, Wellington Partners
  • Renee Aguiar-Lucander, CEO, Calliditas Therapeutics AB
  • Richard Godfrey, CEO, BerGenBio ASA
  • Richard Ward, Director, Search and Evaluation, AstraZeneca
  • Roger Bullock, Chief Medical Officer, Oryzon Genomics S.A
  • Sam Fazeli, Head of Reseach, Senior Pharmaceuticals Analyst, Bloomberg Intelligence
  • Sascha Bucher, VP, Head of Basel Office & Global Transactions, Roivant Sciences GmbH
  • Sebastien Petitet, CCO, Brenus Pharma
  • Shafique Virani, Chief Corporate Development Officer, Recursion Pharmaceuticals
  • Sijme Zeilemaker, COO, Immunicum AB
  • Silvio Belletti, Managing Director & Partner, Healthcare , Boston Consulting Group
  • Søren Bjønness, Director – Switzerland Representative, Euronext Paris S.A.
  • Søren Møller, Managing Partner, Novo Holdings A/S
  • Stephanie Léouzon, Partner & Head of Europe, Torreya Partners LLP
  • Steven Kelly, President & CEO, Carisma Therapeutics Inc.
  • Sumant Kulkarni, Managing Director, Biotechnology Equity Research, Canaccord Genuity LLC
  • Susanna Obad, Director of Business Development, Partnering, F. Hoffmann-La Roche Ltd.
  • Ted Fjällman, CEO, Prokarium Ltd.
  • Thijs Cohen Tervaert, Director, INKEF Capital BV
  • Thomas Shrader, Managing Director & Healthcare Analyst, BTIG, LLC
  • Tim Luker, VP, Search & Evaluation – Emerging Technology & Innovation, Corporate BD, Eli Lilly and Company
  • Vanela Bushi, Director, Portfolio Strategy & Transactions, Syneos Health, LLC
  • More TBA…

Annual Biotech in Europe Forum 2020

European Digital Health Calendar

 

Details

Start:
September 21
End:
September 24
Event Categories:
,
Event Tags:
, ,
Website:
https://www.sachsforum.com/20bef-about.html#

Venue

Online

Organizer

Sachs Forum
Website:
https://www.sachsforum.com/